European Medicines Agency (EMA) has claimed that two-dose COVID-19 vaccines are vital in ensuring maximum protection against the Delta variant, the highly transmissible strain of Coronavirus which first emerged from India.
In an official statement, EMA said that preliminary data has confirmed that both doses of two-dose Coronavirus vaccines are required to develop adequate levels of protection against the Delta strain.
EMA urged countries to speed up their COVID-19 vaccination campaigns, adding that sticking to the gap between the two doses recommended by the vaccine manufacturers is imperative in achieving protection against the Delta variant.
